Supportive Care News & Features
As key biologics near the end of their patent-protection periods, industry is preparing for legal battles over biosimilar versions.
Research highlights how lack of guidelines regarding illness and adequate staffing at hospitals may be reason for oncologists working while sick.
Patients enrolled in hospice care had lower rates of healthcare utilization, and their costs for care were less during their last year of life.
Poor health outcomes for many survivors, especially survivors of multiple myeloma, pancreatic cancer.
Alternative therapies may be safely combined with traditional cancer treatments.
More in Supportive Care
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Inadequate pain management, baseline pain severity linked to pain deterioration
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.
Intrathecal Therapy Cost-Effective for Patients with Cancer Pain Who Have a Favorable Life-Expectancy
In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.
Routine data collection and feedback at point-of-care improves most patient outcomes in hospice and palliative care.
A third of patients beginning palliative care die within a week.
Greatest risk of burnout in palliative care for younger doctors and those working more than 50 hours per week.
Palliative Care in Oncology Symposium: Limited time, support, and case management among barriers that hinder ability to provide palliative care.
Palliative Care in Oncology Symposium: Dispositional mindfulness may promote flourishing when confronting cancer.
Onartuzumab with weekly paclitaxel with or without bevacizumab does not prolong the corrected QT (QTc) interval.
Supportive treatment, rather than systemic corticosteroid treatment, may be best in melanoma with ipilimumab-related hypophysitis.
Splenic volume increase is independently linked with major postoperative complications following hepatic resection in metastatic colorectal cancer.
Sarcopenia is a predictor of dose-limiting toxicity in oesophagogastric cancer with neo-adjuvant chemotherapy.
The relationship and frequency skin reactions in urothelial carcinoma who are being treated only cabozantinib evaluated.
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- Multiple myeloma: Optimal management and long-term disease control
- Coffee May Decrease Risk of Malignant Melanoma
- ASCO Announces Chronic Leukemia Treatment as Cancer Advance of the Year
- LDVP Regimen Following Radiotherapy Effective for Stage III/IV T-Cell Lymphoma
- Brentuximab Vedotin Demonstrates Significant Activity in B-Cell Lymphoma
- Contraceptive Use Linked to Higher Risk of Glioma
- Bevacizumab Plus Temozolomide Produces Low Response in Newly-Diagnosed Glioblastoma
- Standard-Dose vs. High-Dose Chemoradiotherapy With, Without Cetuximab for Lung Cancer
- Abiraterone Acetate Prolongs Survival in Metastatic Prostate Cancer
- CancerLinQTM Enrolls Practices, Prepares to Usher in 'Big Data Oncology' Era
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|